Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew W Segar

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
The American Journal of Cardiology|June 9, 2023
Risk Stratification in Patients Who Underwent Percutaneous Left Atrial Appendage OcclusionMatthew W Segar, Allan Zhang, Robert D Paisley, et al.
Circulation. Cardiovascular Quality and Outcomes|November 9, 2020
Association of Medicaid Expansion With Rates of Utilization of Cardiovascular Therapies Among Medicaid Beneficiaries Between 2011 and 2018Andrew Sumarsono, Hussain Lalani, Matthew W Segar, et al.
The American Journal of Cardiology|November 24, 2021
Phenomapping a Novel Classification System for Patients With Destination Therapy Left Ventricular Assist DevicesNicholas S Hendren, Matthew W Segar, Lin Zhong, et al.
European Journal of Heart Failure|August 26, 2025
Diuretic resistance and the efficacy of hydrochlorothiazide in acute decompensated heart failure: A post-hoc analysis of the CLOROTIC trialAmbarish Pandey, Matthew W Segar, Neil Keshvani, et al.
JAMA Cardiology|November 18, 2020
Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection FractionMatthew W Segar, Ravi B Patel, Kershaw V Patel, et al.
JAMA Cardiology|November 13, 2020
Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Trial (SPRINT)Shreya Rao, Matthew W Segar, Adam P Bress, et al.
Texas Heart Institute Journal|October 27, 2023
Incidence, Risk Score Performance, and In-Hospital Outcomes of Postoperative Atrial Fibrillation After Cardiac SurgeryMatthew W Segar, Alexander Marzec, Mehdi Razavi, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 2, 2024
Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trialAmbarish Pandey, Kershaw V Patel, Matthew W Segar, et al.
JACC. Advances|May 28, 2026
Design, Characteristics, and Implementation of the Financial Support for Low-Income Patients with Heart Failure TrialSyed K Rizvi, Neil Keshvani, Anand K Jain, et al.
Journal of the American College of Cardiology|October 15, 2021
Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling AdultsMatthew W Segar, Muhammad Shahzeb Khan, Kershaw V Patel, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
The American Journal of Cardiology|June 9, 2023
Risk Stratification in Patients Who Underwent Percutaneous Left Atrial Appendage OcclusionMatthew W Segar, Allan Zhang, Robert D Paisley, et al.
Circulation. Cardiovascular Quality and Outcomes|November 9, 2020
Association of Medicaid Expansion With Rates of Utilization of Cardiovascular Therapies Among Medicaid Beneficiaries Between 2011 and 2018Andrew Sumarsono, Hussain Lalani, Matthew W Segar, et al.
The American Journal of Cardiology|November 24, 2021
Phenomapping a Novel Classification System for Patients With Destination Therapy Left Ventricular Assist DevicesNicholas S Hendren, Matthew W Segar, Lin Zhong, et al.
European Journal of Heart Failure|August 26, 2025
Diuretic resistance and the efficacy of hydrochlorothiazide in acute decompensated heart failure: A post-hoc analysis of the CLOROTIC trialAmbarish Pandey, Matthew W Segar, Neil Keshvani, et al.
JAMA Cardiology|November 18, 2020
Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection FractionMatthew W Segar, Ravi B Patel, Kershaw V Patel, et al.
JAMA Cardiology|November 13, 2020
Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Trial (SPRINT)Shreya Rao, Matthew W Segar, Adam P Bress, et al.
Texas Heart Institute Journal|October 27, 2023
Incidence, Risk Score Performance, and In-Hospital Outcomes of Postoperative Atrial Fibrillation After Cardiac SurgeryMatthew W Segar, Alexander Marzec, Mehdi Razavi, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 2, 2024
Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trialAmbarish Pandey, Kershaw V Patel, Matthew W Segar, et al.
JACC. Advances|May 28, 2026
Design, Characteristics, and Implementation of the Financial Support for Low-Income Patients with Heart Failure TrialSyed K Rizvi, Neil Keshvani, Anand K Jain, et al.
Journal of the American College of Cardiology|October 15, 2021
Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling AdultsMatthew W Segar, Muhammad Shahzeb Khan, Kershaw V Patel, et al.
Pageof 7